Department of Biostatistics and Health Informatics, Institute of Psychiatry, Psychology and Neuroscience, King's College London, De Crespigny Park, London SE5 8AF, United Kingdom.
North Bristol NHS Trust, Bristol, Northern Ireland, United Kingdom.
J Affect Disord. 2022 Feb 15;299:118-125. doi: 10.1016/j.jad.2021.11.031. Epub 2021 Nov 16.
Acute effects of COVID-19 can be life-threatening. Alterations in mental health during the active infection have been documented, but the long-term consequences are less clear.
A systematic review was undertaken to investigate the effect of COVID-19 infection on long-term mental health outcomes. Three databases [PubMed, Medline (Ovid) and Cochrane library] were searched between 1st October 2019 and 29th August 2021 with additional hand searching to identify all published studies reporting symptoms of generalised anxiety, depression, post-traumatic stress disorder (PTSD), or sleep disturbance in participants at least one month after COVID-19 infection. The prevalence and mean symptom score of each were assessed.
Eight hundred and eighty five studies were found, of which 33 were included in the review involving a total of 6743 participants. The studies' risk of bias were typically fair quality. The median study age of participants was 57.8 years (IQR 49.3-60.7), with 63.0% male (IQR 57.0%-73.0%). Participants typically experienced no or mild symptoms of long-term anxiety (GAD-7, STAI-S, HADS) and depression (PHQ-9, BDI, PHQ-2, HADS). Prevalence varied depending on the measurement tool. Sleep disturbances (primarily insomnia) were most commonly reported as mild. PTSD prevalence was similar to anxiety and depression.
The overall effect of the pandemic has been linked with worsening psychiatric symptoms. However, the long-term effect from direct COVID-19 infection has been associated with no or mild symptoms. Studies exhibited the long-term prevalence of anxiety, depression, PTSD, and sleep disturbances to be comparable to general population levels.
COVID-19 的急性影响可能危及生命。在积极感染期间,心理健康的改变已经有记录,但长期后果尚不清楚。
进行了一项系统评价,以调查 COVID-19 感染对长期心理健康结果的影响。在 2019 年 10 月 1 日至 2021 年 8 月 29 日期间,我们在三个数据库[PubMed、Medline(Ovid)和 Cochrane 图书馆]中进行了搜索,并进行了额外的手工搜索,以确定所有发表的研究报告,这些研究报告在 COVID-19 感染后至少一个月,参与者出现广泛性焦虑、抑郁、创伤后应激障碍(PTSD)或睡眠障碍的症状。评估了每种症状的患病率和平均症状评分。
共发现 885 项研究,其中 33 项研究纳入了本综述,共涉及 6743 名参与者。研究的偏倚风险通常为中等质量。参与者的中位年龄为 57.8 岁(IQR 49.3-60.7),男性占 63.0%(IQR 57.0%-73.0%)。参与者通常没有或仅有轻度的长期焦虑(GAD-7、STAI-S、HADS)和抑郁(PHQ-9、BDI、PHQ-2、HADS)症状。患病率取决于测量工具。睡眠障碍(主要是失眠)最常被报告为轻度。PTSD 的患病率与焦虑和抑郁相似。
大流行的总体影响与精神症状恶化有关。然而,直接 COVID-19 感染的长期影响与无或轻度症状相关。研究表明,焦虑、抑郁、PTSD 和睡眠障碍的长期患病率与一般人群水平相当。